Cargando…

Comment on “Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”

Detalles Bibliográficos
Autores principales:	Benini, Anna, Fumagalli, Guido Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539929/ https://www.ncbi.nlm.nih.gov/pubmed/28804722 http://dx.doi.org/10.1155/2017/7698452

Ejemplares similares

Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction
por: Ahmad, Ijaz, et al.
Publicado: (2016)

Corrigendum to “Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”
por: Ahmad, Ijaz, et al.
Publicado: (2017)

Comment on “Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States”
por: Barco, Stefano, et al.
Publicado: (2021)

Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants
por: Standing, Joseph F
Publicado: (2022)

Comment on: “Understanding required to consider AI applications to the field of ophthalmology”
por: Martins, Thiago Goncalves dos Santos
Publicado: (2022)

Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin
por: Sou, Tomás, et al.
Publicado: (2020)

PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against Streptococcus suis in Piglets
por: Huang, Anxiong, et al.
Publicado: (2022)

500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?
por: Honore, Patrick M., et al.
Publicado: (2020)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
por: San Martín, Betty, et al.
Publicado: (2019)

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
por: Zhou, Yu-Feng, et al.
Publicado: (2020)

PK/PD modeling supports the dose-escalation decision in VIKING
por: Lovern, M, et al.
Publicado: (2010)

Comment on “Impact of Dose and Sensitivity Heterogeneity on TCP”
por: Grusell, Erik
Publicado: (2015)

Comment on: “Low-Dose Ketamine for Outpatient Hysteroscopy.”
por: Raghuraman, M.S.
Publicado: (2021)

Accidental self-inoculation of a veterinary field worker with Calf Paratyphoid Vaccine
por: Whittaker, David E.
Publicado: (2021)

Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation?
por: Kothekar, Amol, et al.
Publicado: (2020)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug‐disease modelling for dosing regimen optimization
por: Sturm, Stefan, et al.
Publicado: (2020)

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
por: Wang, Chuhui, et al.
Publicado: (2021)

PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK‐PD modeling from nonclinical to clinical development
por: Oggianu, Laura, et al.
Publicado: (2023)

Comment on Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
por: Akbulut, Sami, et al.
Publicado: (2020)

Comment on “Complete Androgen Insensitivity Syndrome: Optimizing Diagnosis and Management”
por: Balsamo, Antonio, et al.
Publicado: (2014)

Comment on “Applicability of different scoring systems in outcome prediction of patients with mixed drug poisoning-induced coma”
por: Zamani, Nasim, et al.
Publicado: (2012)

Research on the mechanism of drug–drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial
por: Zhang, Wantong, et al.
Publicado: (2018)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

Comment on “New Antioxidant Drugs for Neonatal Brain Injury”
por: Lakatos, Lajos, et al.
Publicado: (2015)

Letter to the editor: “Comment on: Application of the optimized carbon monoxide rebreathing method for the measurement of total haemoglobin mass in chronic liver disease”
por: Ahlgrim, Christoph, et al.
Publicado: (2020)

Response to: Comment on “Complete Androgen Insensitivity Syndrome: Optimizing Diagnosis and Management”
por: Laganà, Antonio Simone, et al.
Publicado: (2014)

Population pharmacokinetic (PopPK) modelling indicates that patients switching to BAY 81‐8973 from rFVIII‐FS can continue their dosing schedule with improved protection
por: Solms, Alexander, et al.
Publicado: (2020)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

Author Response: Comments on Evaluation of Central and Peripheral Visual Field Concordance in Glaucoma
por: Odden, Jamie L., et al.
Publicado: (2016)

Comment on: “Using Field Based Data to Model Sprint Track Cycling Performance”
por: Douglas, Jamie
Publicado: (2021)

Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
por: Gibbons, Jacqueline A.
Publicado: (2015)

Response to letter to the editor: Comment on “Mutagenic damage among bronchiectasis patients attending in the pulmonology sector of a hospital in southern Brazil”
por: Ramos, Daniela Fernandes, et al.
Publicado: (2023)

Comment on: “Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs”
por: Eerdekens, M., et al.
Publicado: (2020)

Comment on “The Use of Pulsed Electromagnetic Fields to Promote Bone Responses to Biomaterials In Vitro and In Vivo”
por: Ramirez-Vazquez, Raquel, et al.
Publicado: (2019)

Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections
por: Ling, Chau Wei, et al.
Publicado: (2022)

Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions
por: Grant, Joshuaine, et al.
Publicado: (2023)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
por: Xiao, Xia, et al.
Publicado: (2021)

Comment on the published article: Accidental injection of succinylcholine into epidural space as a test dose
por: Solanki, Sohan L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2b04flnchl8s7rmk28jdtgivi9